Navigation Links
Drug to Prevent Preterm Labor Shows Little Benefit
Date:11/26/2008

No difference found between intensive nifedipine therapy and placebo, researchers say

WEDNESDAY, Nov. 26 (HealthDay News) -- A muscle relaxant drug widely used to prevent premature birth when women go into early labor is no more effective than a placebo at maintaining pregnancy, after the initial spell of preterm labor is stopped.

So say U.S. researchers who conducted the first ever placebo-controlled test of nifedipine and its effect on premature delivery with prolonged treatment. The study included 71 women who'd been successfully treated for preterm labor between 24 and 34 weeks of pregnancy. The women were randomly assigned to receive either nifedipine or placebo every six hours until 37 weeks of pregnancy or delivery, whichever came first.

The team found no differences between the two groups of women in terms of whether their pregnancies lasted until 37 weeks; of how long delivery was delayed; or in their babies' gestational age, birth weight and complications of prematurity. About 40 percent of women in both groups reached 37 weeks of pregnancy, with delivery delayed an average of one month.

The study is published in the December issue of the journal Obstetrics & Gynecology.

"Medication use should be minimized in pregnancy unless it's clearly indicated," lead author Dr. Deirdre Lyell, an assistant professor of obstetrics and gynecology at Stanford University School of Medicine, noted in a school news release.

Serious side effects are rare in pregnant women treated with nifedipine, she said, but even a low risk isn't worthwhile if a drug provides no benefit.

"We all want to prevent preterm birth, but prolonged treatment with nifedipine doesn't appear to be the answer," said Lyell, who believes a larger study of nifedipine is warranted.

More information

The U.S. National Institute of Child Health and Human Development has more about

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Stanford/Packard study shows no benefit from drug widely used to prevent premature births
2. Drug Abuse and Violence Prevention Program Generates $16 Million in Potential Savings
3. US$18.5 million grant makes male circumcision a top-tier HIV prevention strategy
4. The 5-Percent Plan: Preventing Diabetes and Heart Disease
5. Heartworm Disease Prevention Protects Pets, Wallets
6. Robert Wood Johnson Foundation Announces Grant Recipients for $18 Million Dollar Initiative to Prevent Intimate Partner Violence
7. Ginkgo Biloba for Prevention of Dementia
8. Stay Upbeat, Exercise to Help Prevent Cancer in Old Age
9. Indoor Allergy Week - Cleanaer™, the New Air Purifier that Helps Prevent Spread of the Common Cold While Removing Airborne Allergen
10. Vitamin C, E Supplements Wont Help Prevent Cancer
11. Early Life Peanut Consumption Might Prevent Allergy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug to Prevent Preterm Labor Shows Little Benefit
(Date:10/31/2014)... 31, 2014 Monica Williams-Murphy MD ... all too well the chaos that can occur for ... “The vast majority of Americans who come into the ... are completely unprepared for the moment and so are ... can serve as a catalyst for a family to ...
(Date:10/31/2014)... With all the preparations families carry ... they may overlook one critical area – the potential ... school performance and even behavior. Typical children’s vision screenings ... progressive vision problems, and to address this challenge, Dr. ... initiative: The Awesome Eyes Student Vision Program. , ...
(Date:10/31/2014)... 2014 (HealthDay News) -- Surgery for low back pain ... the United States you live, a new report says. ... back pain at some point in their lives, and ... care for a spine problem," co-author Brook Martin, of ... said in a college news release. In spinal ...
(Date:10/31/2014)... of treatment and cost, patients with early stage ... irradiation (APBI) with proton therapy versus whole breast ... University of Texas MD Anderson Proton Therapy Center. ... based on typical patient characteristics, researchers used Medicare ... different types of partial and whole breast irradiation ...
(Date:10/31/2014)... a lab device to give cancer researchers an unprecedented ... cells spread through the body, causing more than 90 ... how tumor cells travel, the device could uncover new ... from the university,s Whiting School of Engineering and its ... their new system recently in the journal Cancer ...
Breaking Medicine News(10 mins):Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3
... dose to the breast and lungs before deciding which CT ... new study cautions. The study compared organ doses to ... found a change in protocol could decrease breast radiation dose ... breast skin and parenchyma were found with our standard thoracic ...
... or anxiety states are often associated with disturbances ... are compounds that are released from the synapses ... of neighboring neurons. Thus, as their name suggests, ... serotonin transporter (SERT) is responsible for reuptake of ...
... PROVIDENCE, R.I. Peter J. Snyder, Ph.D., vice president ... 10 Ig Nobel Prize awards during the annual ceremony ... and colleagues from the University of Melbourne and Yale Medical ... acute urge to void the bladder can have the same ...
... at least on the healthy part. "Early to bed and early ... youths keep slimmer and more physically active than their night-owl peers, ... A study in the Oct. 1 issue of the journal ... participants, ages 9 to 16, and compared their weights and uses ...
... New America Media (NAM) have selected 16 reporters for ... in its second year. They represent a wide range of mainstream ... Arizona to Korea Daily Atlanta. The fellows will convene during ... to 22 in Boston and tap into over 500 presentations ...
... -- Working rotating shifts is not as potentially unhealthy ... research that suggests modern shift patterns may not carry ... shift schedules. "Recent research has suggested shift work ... mechanism responsible for this observation is still unknown," the ...
Cached Medicine News:Health News:Combating mood disorders 2Health News:Lifespan researcher wins Ig Nobel Prize 2Health News:Early to bed and early to rise -- study suggests it's keeping kids leaner 2Health News:Journalism fellows promise in-depth portrayal of aging in a diverse America 2Health News:Journalism fellows promise in-depth portrayal of aging in a diverse America 3Health News:Journalism fellows promise in-depth portrayal of aging in a diverse America 4Health News:Modern Shift Work Patterns May Be Less Harmful to Health 2
(Date:10/31/2014)... 31, 2014 Mast Therapeutics, Inc. (NYSE MKT: ... for the quarter ended September 30, 2014. ... said:  "The third quarter was productive for Mast. Consistent with ... MST-188 for sickle cell disease is on track to ... have opened 50 study sites in the U.S. and ...
(Date:10/31/2014)... October 31, 2014 Oramed ... pharmaceutical company focused on the development of oral ... host a conference call to discuss the clinical ... ORMD-0801, the company,s proprietary oral insulin capsules, to ... 2014 at 10:00 a.m. Eastern time. ...
(Date:10/31/2014)... Investor-Edge has initiated coverage on the following ... Pharmaceuticals Inc. (NASDAQ: ISIS ), Halozyme Therapeutics ... (NASDAQ: ACAD ), and Synta Pharmaceuticals Corporation ... be accessed at: http://investor-edge.com/register . On ... 4,566.14, up 0.37%, the Dow Jones Industrial Average advanced ...
Breaking Medicine Technology:Mast Therapeutics Reports Third Quarter 2014 Financial Results 2Mast Therapeutics Reports Third Quarter 2014 Financial Results 3Mast Therapeutics Reports Third Quarter 2014 Financial Results 4Mast Therapeutics Reports Third Quarter 2014 Financial Results 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 6Mast Therapeutics Reports Third Quarter 2014 Financial Results 7Mast Therapeutics Reports Third Quarter 2014 Financial Results 8Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: